HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

about

Novel directions in HIV-1 vaccines revealed from clinical trials Lessons learned from HIV vaccine clinical efficacy trials.Vaccine development for syphilis.Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence

P2860

Q33645528-80313584-A3B8-46AB-8E61-A7CB43B41ABE Q37724091-DB2CB95C-44EC-47C8-B68E-8292E373F6C7 Q42101765-FB4AD31A-DAE1-49B3-80E0-2471F1905F0E Q58595713-EE2C4361-755A-4349-8B7F-20F11BEDCF79

P2860

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

Item

http://www.wikidata.org/entity/Q36464748

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

@ast

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

@en

type

Item

label

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

@ast

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

@en

prefLabel

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

@ast

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

@en

P1476

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

@en

P2093

Cecilia A Morgan

http://www.w3.org/2001/XMLSchema#string

James G Kublin

http://www.w3.org/2001/XMLSchema#string

Peter B Gilbert

http://www.w3.org/2001/XMLSchema#string

Steve G Self

http://www.w3.org/2001/XMLSchema#string

Tracey A Day

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

Statistical evaluation of HIV vaccines in early clinical trials.

Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation.

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.

Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines

Some design issues in phase 2B vs phase 3 prevention trials for testing efficacy of products or concepts

Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine

P304

245-254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/CLI.12.8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Julie McElrath

Lawrence Corey

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23243491

http://www.w3.org/2001/XMLSchema#string

P932

3521567

http://www.w3.org/2001/XMLSchema#string

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

about

P2860

P2860

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932